Prestige Biologics Co., Ltd. (KOSDAQ:334970)
South Korea · Delayed Price · Currency is KRW 2,920.00
-105.00 (-3.47%)
At close: Jan 19, 2026
Prestige Biologics Market Cap
Prestige Biologics has a market cap or net worth of 227.04 billion as of January 16, 2026. Its market cap has decreased by -42.50% in one year.
Market Cap
227.04B
Enterprise Value
315.38B
Revenue
13.36B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,920.00
Market Cap Chart
Since March 11, 2021, Prestige Biologics's market cap has decreased from 613.27B to 227.04B, a decrease of -62.98%. That is a compound annual growth rate of -18.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 19, 2026 | 227.04B | -3.79% |
| Dec 30, 2025 | 235.98B | -40.12% |
| Dec 30, 2024 | 394.06B | 46.25% |
| Dec 28, 2023 | 269.45B | 46.01% |
| Dec 29, 2022 | 184.55B | -59.28% |
| Dec 30, 2021 | 453.18B | -26.10% |
| Mar 11, 2021 | 613.27B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 975.53T |
| SK hynix | 521.98T |
| Hyundai Motor Company | 99.30T |
| LG Energy Solution | 91.49T |
| Samsung Biologics | 90.13T |
| Hanwha Aerospace | 66.83T |
| HD Hyundai Heavy Industries | 65.29T |
| Doosan Enerbility | 61.04T |